Sotera Health (NASDAQ:SHC) Shares Break Above 50 Day Moving Average – What’s Next?

Sotera Health Company (NASDAQ:SHC) shares crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $18.55 and traded as high as $18.82. Sotera Health shares last traded at $18.65, with a volume of 2,154,305 shares traded.

Analyst Ratings Changes

A number of research firms have recently issued reports on SHC. Barclays increased their target price on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Weiss Ratings lowered Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. Piper Sandler restated an “overweight” rating and issued a $25.00 price target on shares of Sotera Health in a report on Tuesday, September 8th. Citigroup increased their price objective on shares of Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 25th. Eight equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.38.

Sotera Health Stock Performance

The firm has a market capitalization of $5.18 billion, a PE ratio of 22.00 and a beta of 1.85. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. The stock has a 50-day moving average price of $18.52 and a 200-day moving average price of $17.04.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%. The business had revenue of $321.38 million for the quarter, compared to analysts’ expectations of $309.70 million. During the same quarter in the previous year, the firm posted $0.20 earnings per share. The company’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, research analysts expect that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Insider Activity at Sotera Health

In related news, Chairman Michael Petras, Jr. sold 850,000 shares of Sotera Health stock in a transaction on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the sale, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Company insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Sotera Health in the 3rd quarter worth about $29,000. Meeder Asset Management Inc. acquired a new position in Sotera Health in the second quarter worth about $37,000. Root Financial Partners LLC grew its stake in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after purchasing an additional 1,455 shares in the last quarter. Provenance Wealth Advisors LLC bought a new stake in Sotera Health in the third quarter valued at about $42,000. Finally, Nykredit A S bought a new stake in Sotera Health in the second quarter valued at about $50,000. 91.03% of the stock is currently owned by institutional investors.

About Sotera Health

Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.